|
Oct 8
|
AtriCure to Announce Third Quarter 2024 Financial Results
|
|
Oct 1
|
AtriCure Receives CE-Mark for the EnCompass® Clamp
|
|
Aug 28
|
AtriCure's Shares Likely to Benefit From New AtriClip Device Sales
|
|
Aug 28
|
AtriClip FLEX-Mini device treatment begins with first patient
|
|
Aug 27
|
AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ Device
|
|
Aug 23
|
AtriCure's (ATRC) AtriClip Receives Expanded CE-Mark Indication
|
|
Jul 29
|
AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
|
|
Jul 24
|
AtriCure (ATRC) Gains China Approval for AtriClip LAA System
|
|
Jul 23
|
AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China
|
|
Jun 27
|
Exploring Three Undervalued Small Caps With Insider Action In The Region
|
|
Jun 27
|
Exploring Undervalued Small Caps With Insider Buying In The United States June 2024
|
|
Jun 25
|
AtriCure Leads Three Undervalued Small Caps With Insider Actions In The United States
|
|
Jun 24
|
Exploring Undervalued Small Caps With Insider Actions In The United States June 2024
|
|
Jun 14
|
Is AtriCure, Inc. (NASDAQ:ATRC) Trading At A 48% Discount?
|
|
May 15
|
AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
|
|
May 4
|
AtriCure, Inc. (NASDAQ:ATRC) Just Reported, And Analysts Assigned A US$47.33 Price Target
|
|
May 3
|
The past three years for AtriCure (NASDAQ:ATRC) investors has not been profitable
|
|
May 3
|
AtriCure First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
May 2
|
AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript
|
|
May 2
|
AtriCure Inc (ATRC) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
|